Nederlands
English
Home
Currently selected
Research
Training
Conferences
Business opportunities
About VIB
Donate
Home
>
News
Refine
Theme
About VIB (92)
Arabidopsis (3)
Bioinformatics (11)
Biotech basics (1)
Cancer (69)
Cardiovascular medicine (11)
Cell biology (9)
Grand Challenges (4)
Immunology (32)
Inflammation and immunity (55)
Microbiology (23)
Model Organisms (4)
Mouse (2)
Neuroscience (59)
Plant biology (41)
Proteomics (5)
Research Areas (3)
Science ethics (2)
Structural biology (17)
Systems biology (2)
Yeast (1)
Category
BioInformatics Training and Service facility (1)
Business opportunities (8)
Developmental biology (1)
Event (8)
News (34)
Research services (5)
Page Content Zone 1
News
Targeting drugs to the brain
24 September 2019
According to the World Health Organization, neurological disorders affect up to one billion people worldwide. These neurological disorders affect people in all countries, irrespective of age, sex, education, or income.
Spartacus better treatment options for spondyloarthritis
24 September 2019
About a fifth of Europeans suffers from musculoskeletal disorders. A substantial subgroup are the rheumatic conditions. Within the rheumatic disorders, spondyloarthritis is a group of inflammatory diseases that cause joint inflammation, or arthritis
Stakeholders views
24 September 2019
EU-LIFE urges to double the budget for Horizon Europe
23 September 2019
EU-LIFE urges the EU Council and the European Parliament to double Horizon Europe’s budget compared to Horizon 2020, to 150 Billion Euros and within it, to double the budget for discovery research, including the well-proven European Research Council.
New insights into how astrocytes help the brain process information
12 September 2019
A collaboration between Vincent Bonin (NERF) and Matthew Holt (VIB-KU Leuven) reveals that noradrenaline plays a key role in how astrocytes – star-shaped cells in the brain closely associated with neurons – track distinct information during behavior.
Charlotte Scott is awarded an ERC Starting Grant
3 September 2019
VIB’s Charlotte Scott has been awarded an ERC starting grant worth €1.5 million. These renowned, highly competitive grants aim to help individual scientists and scholars to build their own teams and conduct pioneering research across all disciplines.
Understanding probiotic yeast
30 August 2019
Researchers led by Prof. Johan Thevelein (VIB-KU Leuven Center for Microbiology) have discovered that Saccharomyces boulardii, a yeast with probiotic properties, produces uniquely excessive amounts of acetic acid, the main component of vinegar.
A PoEM on breast cancer metastasis
28 August 2019
Scientists from the group of Massimiliano Mazzone (VIB-KU Leuven) identified a novel subset of immune cells, called Podoplanin-expressing macrophages (PoEMs), that change the tissues near a tumor in a way that promotes the spreading of cancer cells.
Symposium 'Gene technology today: a practical approach' - 20 Sept. 2019, organised by the BCCM/GeneCorner Plasmid Collection
26 August 2019
BCCM/GeneCorner, the Belgian Plasmid Collection which is hosted by the VIB-UGent Center for Inflammation Research, organises its second symposium on September 20, 2019, entitled 'Gene technology today: a practical approach'.
Epilepsy causes brain's defenses to collapse
23 August 2019
What happens during an epileptic seizure? A recent study from the group of VIB alumnus Emre Yaksi (currently NTNU , Norway), which started during the team’s time at VIB, suggests that seizures occur after certain defense cells in the brain break down.
International top talents join Leuven neuroscience research community
23 August 2019
The VIB-KU Leuven Center for Brain & Disease Research has attracted two new faculty members. Sandrine Da Cruz will lead a laboratory focusing on the mechanisms of ALS, Lynette Lim will lead a group focusing on the development of neuronal circuits.
Antibodies you can eat: A therapeutic revolution from the Callewaert lab and collaborators
10 August 2019
VIB-UGent, VIB-VUB and UGent labs have developed a new antibody technology that combines the advantages of antibody-based therapies with the convenience of oral drug administration.
Quickscan II
4 August 2019
VIB's scientific publications second quarter 2019
Walter Fiers, founder of VIB and pioneer of biotechnology in Flanders, passed away
30 July 2019
Walter Fiers, one of the founders of VIB and an exceptional scientist, passed away on July 28th, 2019.
To become, or not to become... a neuron
25 July 2019
Researchers led by Pierre Vanderhaeghen and Jérôme Bonnefont (VIB-KU Leuven and ULB) have unraveled a new mechanism controlling the switch between growth and differentiation of neural stem cells during brain development.
«Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
Next»
Page Content Zone 2
Page Content Zone 3
Get news updates:
Email updates
Follow us on Twitter
Like us on Facebook
RSS